Table 1.
Population | Adults (aged ≥ 18 years) with type 1 or type 2 diabetes in LMICs who have been identified as needing treatment for DR and/or DMO |
Intervention | Any intervention that seeks to increase uptake and/or completion of treatment for DR and/or DMO among adults with diabetes |
Comparator | Usual care or another intervention seeking to increase uptake and/or completion of treatment for DR and/or DMO |
Outcomes |
1. Proportion of patients initiating treatment for DR and/or DMO among those to whom it is recommended 2. Proportion of patients completing treatment for DR and/or DMO among those to whom it is recommended 3. Proportion of patients completing treatment for DR and/or DMO among those initiating treatment 4. Number and proportion of DR and/or DMO rounds of treatment completed per patient, as dictated by the treatment protocol 5. Cost-effectiveness of intervention to increase DR/DMO treatment uptake or completion |
Study design | Any interventional or observational comparative study |